Stroke Trial, Recruiting NCT05969548 Sponsor: Changping Laboratory Condition: Stroke
Back to Stroke

Stroke Trial, Recruiting

NCT05969548
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People aged between 35 and 75 years old (including those who are exactly 35 or 75).
  • People who have been diagnosed with either an ischemic stroke (caused by a blocked blood vessel) or a hemorrhagic stroke (caused by bleeding in the brain), where the affected area is on the left side of the brain, and whose stroke occurred between 15 days and 6 months ago.
  • People who have been assessed as having aphasia (difficulty with language) using a standardised Chinese language test called the Western Aphasia Battery, with a score below 93.8.
  • People who are experiencing their first-ever stroke.
  • People whose language ability was normal before the stroke, whose first language is Chinese, and who have had at least 6 years of schooling.
  • People who understand the trial and have signed a consent form agreeing to participate.

Who may not be able to join:

  • People who have difficulty with the physical act of speaking (called dysarthria), based on a specific scoring measure (confirm with trial site).
  • People whose aphasia is caused by something other than a single-hemisphere stroke, such as a brain tumour, head injury, Parkinson's disease, or motor neuron disease.
  • People who have an implanted electronic device such as a pacemaker or cochlear implant, any metal objects in their body, a fear of enclosed spaces (claustrophobia), or other reasons that would prevent MRI scanning or a brain stimulation treatment called TMS.
  • People with a history of epilepsy or seizures.
  • People with serious ongoing conditions affecting the heart, lungs, liver, kidneys, or other organs that are not well controlled by standard medication.
  • People with a reduced level of consciousness, based on a specific clinical score (confirm with trial site).
  • People with severely high blood pressure that is difficult to control (malignant hypertension).
  • People with a serious illness such as cancer where life expectancy is estimated to be less than one year.
  • People with severe hearing loss, vision problems, cognitive (thinking or memory) difficulties, or who are otherwise unable to participate in the trial activities.
  • People with severe depression, anxiety, or another diagnosed mental health condition that would prevent them from completing the trial.
  • People who have received brain stimulation treatments such as TMS or transcranial electrical stimulation in the 3 months before joining the trial.
  • People with a history of heavy alcohol use, drug misuse, or other substance abuse.
  • People who are unable to attend follow-up visits due to where they live or other practical reasons.
  • People whose situation includes other findings that the research team considers unsuitable for participation (confirm with trial site).
  • Women who are currently pregnant, breastfeeding, or who are planning to become pregnant or may become pregnant during the trial.
  • People who are currently enrolled in another clinical trial.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 13 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Hesheng Liu, PhD, Changping Laboratory

Phone: 010-80726688

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Changping Laboratory
Registry
ClinicalTrials.gov
Start date
22 September 2023
Est. completion
22 September 2025

Where this trial is recruiting

🇨🇳 China

Primary endpoints

Change in the Western Aphasia Battery scores

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 13 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov